Combinatorial bio-conjugation of gemcitabine and curcumin enables dual drug delivery with synergistic anticancer efficacy and reduced toxicity
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combinatorial bio-conjugation of gemcitabine and curcumin enables dual drug delivery with synergistic anticancer efficacy and reduced toxicity
Authors
Keywords
-
Journal
RSC Advances
Volume 4, Issue 55, Pages 29193-29201
Publisher
Royal Society of Chemistry (RSC)
Online
2014-06-20
DOI
10.1039/c4ra04237a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Macromolecular Bipill of Gemcitabine and Methotrexate Facilitates Tumor-Specific Dual Drug Therapy with Higher Benefit-to-Risk Ratio
- (2014) Manasmita Das et al. BIOCONJUGATE CHEMISTRY
- Novel self-nanoemulsifying formulation of quercetin: Implications of pro-oxidant activity on the anticancer efficacy
- (2014) Amit K. Jain et al. Nanomedicine-Nanotechnology Biology and Medicine
- Enhanced Transfection Efficiency and Reduced Cytotoxicity of Novel Lipid–Polymer Hybrid Nanoplexes
- (2013) Sanyog Jain et al. MOLECULAR PHARMACEUTICS
- Augmented Anticancer Activity of a Targeted, Intracellularly Activatable, Theranostic Nanomedicine Based on Fluorescent and Radiolabeled, Methotrexate-Folic Acid-Multiwalled Carbon Nanotube Conjugate
- (2013) Manasmita Das et al. MOLECULAR PHARMACEUTICS
- Co-encapsulation of Tamoxifen and Quercetin in Polymeric Nanoparticles: Implications on Oral Bioavailability, Antitumor Efficacy, and Drug-Induced Toxicity
- (2013) Amit K. Jain et al. MOLECULAR PHARMACEUTICS
- Solidified Self-Nanoemulsifying Formulation for Oral Delivery of Combinatorial Therapeutic Regimen: Part II In vivo Pharmacokinetics, Antitumor Efficacy and Hepatotoxicity
- (2013) Amit K. Jain et al. PHARMACEUTICAL RESEARCH
- Solidified Self-Nanoemulsifying Formulation for Oral Delivery of Combinatorial Therapeutic Regimen: Part I. Formulation Development, Statistical Optimization, and In Vitro Characterization
- (2013) Amit K. Jain et al. PHARMACEUTICAL RESEARCH
- Effect of co-administration of CoQ10-loaded nanoparticles on the efficacy and cardiotoxicity of doxorubicin-loaded nanoparticles
- (2013) Nitin K. Swarnakar et al. RSC Advances
- Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel
- (2012) Sanyog Jain et al. BIOMATERIALS
- Oral Delivery of Doxorubicin Using Novel Polyelectrolyte-Stabilized Liposomes (Layersomes)
- (2012) Sanyog Jain et al. MOLECULAR PHARMACEUTICS
- Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles
- (2011) Nitin K. Swarnakar et al. BIOMATERIALS
- Improved plasma stability and sustained release profile of gemcitabine via polypeptide conjugation
- (2010) Lik-Voon Kiew et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo
- (2010) Zhimei Song et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Combinatorial Drug Conjugation Enables Nanoparticle Dual-Drug Delivery
- (2010) Santosh Aryal et al. Small
- Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma
- (2009) Fabio Calabrò et al. CANCER
- Synergistic drug combinations tend to improve therapeutically relevant selectivity
- (2009) Joseph Lehár et al. NATURE BIOTECHNOLOGY
- Squalenoylation Favorably Modifies the in Vivo Pharmacokinetics and Biodistribution of Gemcitabine in Mice
- (2008) L. H. Reddy et al. DRUG METABOLISM AND DISPOSITION
- Antitumoral activity of PEG–gemcitabine prodrugs targeted by folic acid
- (2008) Gianfranco Pasut et al. JOURNAL OF CONTROLLED RELEASE
- Preclinical Toxicology (Subacute and Acute) and Efficacy of a New Squalenoyl Gemcitabine Anticancer Nanomedicine
- (2008) L. H. Reddy et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now